Description
Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases.
Indications
- Hypertension.
- Chronic stable angina pectoris.
- Secondary prevention following an acute myocardial infarction
- Supraventricular arrhythmias:
– supportive therapy in sinus tachycardia caused by thyrotoxicosis;
– paroxysmal supraventricular tachycardia (therapeutically or prophylactically);
– atrial fibrillation and atrial flutter; in cases of insufficient response to maximum dosages of cardiac glycosides; as supportive therapy in thyrotoxicosis; if cardiac glycosides are contraindicated or if there is an unfavourable risk/benefit ratio.
- Ventricular arrhythmias:
– ventricular extra systoles (therapeutically or prophylactically), if the extra systoles are the result of an increased sympathetic activity;
– ventricular tachycardia and ventricular fibrillation (prophylactically), especially if the ventricular abnormality is the result of an increased sympathetic activity.
Subject to medical prescription
Pharmaceutical form: 50 mg x 30 film-coated tablets
NHIF code: CF341
ICD: E05.0; E05.1; E05.2; E05.3; E05.4; I10; I11.9; I12.0; I12.9; I13.1; I20.0; I20.8; I45.6; I47.1; I48
